Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aker BioMarine ASAOSL:AKBM -0.15%59 Piotroski F-Score is 4 as of Sep. 20, 2026, which is 20% below its 10-year median of 5.00. GuruFocus rates OSL:AKBM with a GF Score™ of 59/100 and a GF Value™ of kr63.08 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,944 Consumer Packaged Goods companies, Aker BioMarine ASA ranks worse than 67.75% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Aker BioMarine ASA has an F-score of 4 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Aker BioMarine ASA's Piotroski F-Score or its related term are showing as below:
OSL:AKBM'
s Piotroski F-Score Range Over the Past 10 Years
Min: 2 Med: 5 Max: 7
Current: 4
During the past 8 years, the highest Piotroski F-Score of Aker BioMarine ASA was 7. The lowest was 2. And the median was 5.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Aker BioMarine ASA Piotroski F-Score Related Terms
Aker BioMarine ASA Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Aker BioMarine ASA's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:AKBM vs KHC, GIS, MKC: Piotroski F-Score Comparison
For the Packaged Foods subindustry, Aker BioMarine ASA's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aker BioMarine ASA Piotroski F-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Aker BioMarine ASA's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun26) TTM:
Last Year (Jun25) TTM:
Net Income was 3.029189328359 + -55.508813461548 + -26.26554214288 + -50.965257272731 = kr-130 Mil. Cash Flow from Operations was 5.5744860754355 + 113.82448173116 + -105.06216857152 + -58.701549026914 = kr-44 Mil. Revenue was 573.52651283597 + 557.10663692317 + 557.41317214335 + 546.46081409094 = kr2,235 Mil. Gross Profit was 201.94595522393 + 200.84097961542 + 209.1515392859 + 214.24284075759 = kr826 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(3916.3239 + 3976.1533 + 3882.428565 + 3721.0429 + 3928.5135) / 5 = kr3884.892433 Mil. Total Assets at the begining of this year (Jun25) was kr3,916 Mil. Long-Term Debt & Capital Lease Obligation was kr1,757 Mil. Total Current Assets was kr2,030 Mil. Total Current Liabilities was kr781 Mil.
Net Income was 2220.1736345456 + -163.22938215389 + -17.713988571434 + -151.46002523081 = kr1,888 Mil.
Revenue was 527.74619181823 + 573.50864000017 + 562.41913714302 + 569.778190154 = kr2,233 Mil. Gross Profit was 144.51467727274 + 154.40617230774 + 195.96099857148 + 227.70520800006 = kr723 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(8553.13675 + 4191.9947 + 4399.83739 + 4028.45016 + 3916.3239) / 5 = kr5017.94858 Mil. Total Assets at the begining of last year (Jun24) was kr8,553 Mil. Long-Term Debt & Capital Lease Obligation was kr1,603 Mil. Total Current Assets was kr1,968 Mil. Total Current Liabilities was kr750 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Aker BioMarine ASA's current Net Income (TTM) was -130.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Aker BioMarine ASA's return on assets of this year was -0.03312045. Aker BioMarine ASA's return on assets of last year was 0.22071087.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Aker BioMarine ASA's gearing of this year was 0.45237824. Aker BioMarine ASA's gearing of last year was 0.31944538.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Aker BioMarine ASA's current ratio of this year was 2.59949303. Aker BioMarine ASA's current ratio of last year was 2.62483131.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Aker BioMarine ASA's number of shares in issue this year was 0. Aker BioMarine ASA's number of shares in issue last year was 0.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Aker BioMarine ASA's gross margin of this year was 0.3697376. Aker BioMarine ASA's gross margin of last year was 0.32352923.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Aker BioMarine ASA's asset turnover of this year was 0.57056239. Aker BioMarine ASA's asset turnover of last year was 0.26112667.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
0
+
0
+
1
+
0
+
0
+
1
+
1
+
1
=
4
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Aker BioMarine ASA has an F-score of 4 indicating the company's financial situation is typical for a stable company.
Aker BioMarine ASA (OSL:AKBM) has a Piotroski F-Score of 4 as of Sep. 20, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Aker BioMarine ASA and its competitors. This is 20% below median its historical median of 5.00. Over the past decade, Aker BioMarine ASA's Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, Aker BioMarine ASA ranks #1317 out of 1944 companies in the Consumer Packaged Goods industry, placing it in the top 67.7%.
Is Aker BioMarine ASA's Piotroski F-Score too high?
Aker BioMarine ASA's current Piotroski F-Score of 4 is 20% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. Aker BioMarine ASA's value of 4 is 20% below this industry median. Based on the distribution chart, Aker BioMarine ASA ranks #1317 out of 1944 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Aker BioMarine ASA has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's Piotroski F-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Aker BioMarine ASA ranks #1317 out of 1944 companies for Piotroski F-Score. This places Aker BioMarine ASA in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Aker BioMarine ASA's value of 4 is 20% below this benchmark. Historically, Aker BioMarine ASA's own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Aker BioMarine ASA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,944 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aker BioMarine ASA's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Aker BioMarine ASA and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aker BioMarine ASA's current Piotroski F-Score is 4, which is 20% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (OSL:AKBM) is currently considered Significantly Overvalued. The stock's GF Value™ is kr63.08, compared to a current price of kr133.20 — trading 111.2% above its estimated fair value. The current Piotroski F-Score is 4, which is 20% below median its 10-year median of 5.00 and 20% below the Consumer Packaged Goods industry median of 5.00. Aker BioMarine ASA's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Aker BioMarine ASA (OSL:AKBM), the current Piotroski F-Score is 4 as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aker BioMarine ASA (OSL:AKBM) Overvalued in 2026?
Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued.
The current stock price of kr133.20 is trading 111.2% above its estimated GF Value™ of kr63.08.
GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.
Key valuation signals for OSL:AKBM:
Piotroski F-Score: 4 (20% below median its 10-year median of 5.00)
GF Value™: kr63.08 vs. price of kr133.20 (111.2% above fair value)
Industry Position: 20% below the Consumer Packaged Goods median (#1317 of 1944)
No single metric tells the full story. See the OSL:AKBM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
59GF Score
Get the complete analysis for OSL:AKBM
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:AKBM has been successfully added to your 
